{"id":14275,"date":"2026-06-25T09:21:10","date_gmt":"2026-06-25T09:21:10","guid":{"rendered":"https:\/\/glabridinchina.com\/?p=14275"},"modified":"2026-06-25T09:25:43","modified_gmt":"2026-06-25T09:25:43","slug":"eye-area-brightening-addressing-dark-circles-with-glabridin","status":"publish","type":"post","link":"https:\/\/glabridinchina.com\/es\/eye-area-brightening-addressing-dark-circles-with-glabridin\/","title":{"rendered":"Iluminaci\u00f3n del \u00c1rea de los Ojos: Abordando las Ojeras con Glabridina"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"14275\" class=\"elementor elementor-14275\" data-elementor-post-type=\"post\">\n\t\t\t\t<div class=\"elementor-element elementor-element-cc9cd90 e-flex e-con-boxed e-con e-parent\" data-id=\"cc9cd90\" data-element_type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-d07bcf6 elementor-widget elementor-widget-html\" data-id=\"d07bcf6\" data-element_type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t\t  <script type=\"application\/ld+json\">{\n    \"@context\": \"https:\\\/\\\/schema.org\",\n    \"@type\": \"Article\",\n    \"mainEntityOfPage\": {\n        \"@type\": \"WebPage\",\n        \"@id\": \"https:\\\/\\\/glabridinchina.com\\\/eye-area-brightening-addressing-dark-circles-with-glabridin\\\/\"\n    },\n    \"headline\": \"Eye Area Brightening: Addressing Dark Circles with Glabridin\",\n    \"about\": {\n        \"@type\": \"ChemicalSubstance\",\n        \"name\": \"Glabridin\",\n        \"alternateName\": \"\\u5149\\u7518\\u8349\\u5b9a\"\n    },\n    \"publisher\": {\n        \"@type\": \"Organization\",\n        \"name\": \"Huatai Bio-Fine Chemical\",\n        \"url\": \"https:\\\/\\\/glabridinchina.com\"\n    },\n    \"author\": {\n        \"@type\": \"Organization\",\n        \"name\": \"Huatai Bio-Fine Chemical Technical Team\"\n    },\n    \"datePublished\": \"2026\",\n    \"description\": \"A technical guide to formulating dark circle treatments using glabridin, covering the three distinct causes of periorbital darkness, the rationale for anti-inflammatory brightening in the eye area, active system design, and formulation considerations for the periorbital zone.\"\n}<\/script>\n\n  <link rel=\"preconnect\" href=\"https:\/\/fonts.googleapis.com\">\n  <link rel=\"preconnect\" href=\"https:\/\/fonts.gstatic.com\" crossorigin>\n  <link href=\"https:\/\/fonts.googleapis.com\/css2?family=Inter:wght@300;400;500;600;700&family=Merriweather:ital,wght@0,400;0,700;1,400&display=swap\" rel=\"stylesheet\">\n\n  <style>\n    :root {\n      --color-bg:           #f9f9f7;\n      --color-surface:      #ffffff;\n      --color-border:       #e5e2d9;\n      --color-text:         #1c1c1a;\n      --color-text-muted:   #6a6760;\n      --color-accent:       #2d5a3d;\n      --color-accent-light: #edf4ef;\n      --color-accent-mid:   #4a7c5f;\n      --color-warn:         #A0522D;\n      --color-warn-light:   #fef0e6;\n      --color-data-bg:      #f3f1ed;\n      --font-heading:       'Merriweather', Georgia, 'Times New Roman', serif;\n      --font-body:          'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', Helvetica, Arial, sans-serif;\n      --max-width:          800px;\n      --radius:             6px;\n    }\n\n    *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }\n    html { scroll-behavior: smooth; }\n\n    body {\n      font-family: var(--font-body);\n      font-size: 16px;\n      line-height: 1.8;\n      color: var(--color-text);\n      background: var(--color-bg);\n      -webkit-font-smoothing: antialiased;\n    }\n\n    .page-wrap { max-width: 100%; margin: 0 auto; padding: 0 24px 80px; }\n\n    .site-header {\n      border-bottom: 1px solid var(--color-border);\n      padding: 16px 24px;\n      display: flex; align-items: center; gap: 10px;\n    }\n    .site-header .brand { font-size: 14px; font-weight: 600; color: var(--color-accent); text-decoration: none; }\n    .site-header .sep { color: var(--color-border); }\n    .site-header .section-label { font-size: 13px; color: var(--color-text-muted); }\n\n    .article-header { padding: 48px 0 32px; border-bottom: 1px solid var(--color-border); margin-bottom: 40px; }\n    .tag-row { display: flex; gap: 8px; margin-bottom: 16px; flex-wrap: wrap; }\n    .tag {\n      font-size: 11px; font-weight: 600; letter-spacing: 0.07em;\n      text-transform: uppercase; padding: 3px 9px; border-radius: 3px;\n      background: var(--color-accent-light); color: var(--color-accent);\n    }\n    .tag.secondary { background: var(--color-data-bg); color: var(--color-text-muted); }\n\n    h1 {\n      font-family: var(--font-heading);\n      font-size: clamp(24px, 3.5vw, 34px);\n      font-weight: 700; line-height: 1.25;\n      color: var(--color-text); margin-bottom: 16px; letter-spacing: -0.01em;\n    }\n    .article-intro { font-size: 17px; line-height: 1.7; color: var(--color-text-muted); font-weight: 300; max-width: 100%; }\n    .byline { margin-top: 18px; font-size: 13px; color: var(--color-text-muted); display: flex; align-items: center; gap: 12px; flex-wrap: wrap; }\n    .byline strong { color: var(--color-text); font-weight: 600; }\n\n    .article-body h2 {\n      font-family: var(--font-heading); font-size: 20px; font-weight: 700;\n      color: var(--color-text); margin: 48px 0 14px; padding-bottom: 10px;\n      border-bottom: 2px solid var(--color-accent-light); letter-spacing: -0.01em;\n    }\n    .article-body h3 { font-family: var(--font-heading); font-size: 17px; font-weight: 700; color: var(--color-text); margin: 32px 0 12px; }\n    .article-body p { margin-bottom: 16px; }\n    .article-body ul { margin: 10px 0 18px; padding-left: 0; list-style: none; }\n    .article-body ul li { padding: 4px 0 4px 20px; position: relative; }\n    .article-body ul li::before { content: '\u2014'; position: absolute; left: 0; color: var(--color-accent-mid); font-weight: 600; }\n    .article-body strong { font-weight: 600; }\n    .article-body em { font-style: italic; }\n\n    .table-wrap { overflow-x: auto; margin: 20px 0 24px; border-radius: var(--radius); border: 1px solid var(--color-border); }\n    table { width: 100%; border-collapse: collapse; font-size: 14.5px; }\n    thead th {\n      background: var(--color-data-bg); font-weight: 600; font-size: 11px;\n      letter-spacing: 0.05em; text-transform: uppercase; color: var(--color-text-muted);\n      padding: 10px 14px; text-align: left; border-bottom: 1px solid var(--color-border);\n    }\n    tbody td { padding: 9px 14px; border-bottom: 1px solid var(--color-border); vertical-align: top; line-height: 1.55; }\n    tbody tr:last-child td { border-bottom: none; }\n    tbody tr:hover { background: #fafaf6; }\n    td strong { color: var(--color-accent); }\n\n    .callout {\n      border-left: 3px solid var(--color-accent); background: var(--color-accent-light);\n      padding: 14px 18px; border-radius: 0 var(--radius) var(--radius) 0;\n      margin: 20px 0; font-size: 15px; line-height: 1.65;\n    }\n    .callout.warning { border-left-color: var(--color-warn); background: var(--color-warn-light); }\n    .callout p { margin-bottom: 0; }\n    .callout p + p { margin-top: 8px; }\n\n    .cause-card {\n      background: var(--color-surface);\n      border: 1px solid var(--color-border);\n      border-radius: var(--radius);\n      padding: 18px 20px;\n      margin: 16px 0;\n    }\n    .cause-card-title {\n      font-family: var(--font-heading);\n      font-size: 15px; font-weight: 700;\n      color: var(--color-text); margin-bottom: 8px;\n    }\n    .cause-card p { margin-bottom: 8px; font-size: 15px; }\n    .cause-card p:last-child { margin-bottom: 0; }\n\n    .related-section { margin-top: 52px; padding-top: 28px; border-top: 1px solid var(--color-border); }\n    .related-section h2 {\n      font-family: var(--font-body); font-size: 12px; font-weight: 700;\n      margin-bottom: 14px; color: var(--color-text-muted); border: none; padding: 0;\n      text-transform: uppercase; letter-spacing: 0.07em;\n    }\n    .related-links { display: grid; gap: 8px; }\n    .related-link {\n      display: flex; align-items: center; gap: 12px; padding: 12px 14px;\n      background: var(--color-surface); border: 1px solid var(--color-border);\n      border-radius: var(--radius); text-decoration: none; color: var(--color-text);\n      font-size: 14px; transition: border-color 0.15s, background 0.15s;\n    }\n    .related-link:hover { border-color: var(--color-accent); background: var(--color-accent-light); }\n    .related-link-arrow { color: var(--color-accent); font-size: 16px; flex-shrink: 0; margin-left: auto; }\n\n    .cta-box {\n      margin-top: 36px; background: var(--color-accent); border-radius: var(--radius);\n      padding: 24px 28px; display: flex; align-items: center;\n      justify-content: space-between; gap: 20px; flex-wrap: wrap;\n    }\n    .cta-box-text { color: rgba(255,255,255,0.85); font-size: 14px; }\n    .cta-box-text strong { color: #fff; display: block; font-size: 16px; margin-bottom: 3px; font-family: var(--font-heading); }\n    .cta-btn {\n      background: #fff; color: var(--color-accent); text-decoration: none;\n      font-weight: 700; font-size: 13px; padding: 9px 20px; border-radius: 4px;\n      white-space: nowrap; flex-shrink: 0;\n    }\n\n    .references { margin-top: 44px; padding-top: 24px; border-top: 1px solid var(--color-border); }\n    .references h2 {\n      font-family: var(--font-body); font-size: 12px; font-weight: 700;\n      margin-bottom: 12px; color: var(--color-text-muted); border: none; padding: 0;\n      text-transform: uppercase; letter-spacing: 0.07em;\n    }\n    .references ol { padding-left: 18px; }\n    .references li { font-size: 13px; color: var(--color-text-muted); line-height: 1.6; margin-bottom: 7px; }\n\n    .article-footer { margin-top: 36px; padding-top: 18px; border-top: 1px solid var(--color-border); font-size: 12px; color: var(--color-text-muted); line-height: 1.6; }\n  <\/style>\n<\/head>\n<body>\n\n  <div class=\"page-wrap\">\n\n    <header class=\"article-header\">\n      <div class=\"tag-row\">\n        <span class=\"tag\">Solicitud<\/span>\n        <span class=\"tag secondary\">Glabridina<\/span>\n        <span class=\"tag secondary\">Zona ocular<\/span>\n        <span class=\"tag secondary\">Ojeras<\/span>\n      <\/div>\n      <p class=\"article-intro\">Las ojeras se encuentran entre las preocupaciones est\u00e9ticas m\u00e1s comunes en el cuidado de la piel, y entre las que se formulan con mayor frecuencia de forma err\u00f3nea. El error m\u00e1s com\u00fan es aplicar un enfoque general de aclaramiento a un problema que, en la mayor\u00eda de los casos, no est\u00e1 impulsado \u00fanicamente por la producci\u00f3n de melanina. Un aclaramiento eficaz de la zona ocular requiere identificar cu\u00e1l de las tres causas principales es dominante \u2014vascular, estructural o pigmentaria\u2014 y seleccionar activos que aborden el mecanismo subyacente.<\/p>\n      <div class=\"byline\">\n        <span><strong>Huatai Bio-Fine Chemical<\/strong> \u2014 fabricante de activos cosm\u00e9ticos de alta pureza desde 2008<\/span>\n        <span style=\"color:var(--color-border)\">\u00b7<\/span>\n        <span>Publicado 2026<\/span>\n      <\/div>\n    <\/header>\n\n    <article class=\"article-body\">\n\n      <p>Las ojeras se encuentran entre las preocupaciones est\u00e9ticas m\u00e1s comunes en el cuidado de la piel, y entre las que se formulan con mayor frecuencia de forma err\u00f3nea. El error m\u00e1s com\u00fan es aplicar un enfoque general de aclaramiento a un problema que, en la mayor\u00eda de los casos, no est\u00e1 impulsado \u00fanicamente por la producci\u00f3n de melanina. Un aclaramiento eficaz de la zona ocular requiere identificar cu\u00e1l de las tres causas principales es dominante \u2014vascular, estructural o pigmentaria\u2014 y seleccionar activos que aborden el mecanismo subyacente.<\/p>\n\n      <p>La glabridina es relevante en las tres v\u00edas de las ojeras, pero con diferentes niveles de contribuci\u00f3n. Comprender la distinci\u00f3n determina si la glabridina debe ser el activo principal, un coactivo o un ingrediente de apoyo en una formulaci\u00f3n ocular determinada.<\/p>\n\n      <h2>Las Tres Causas de las Ojeras<\/h2>\n\n      <div class=\"cause-card\">\n        <div class=\"cause-card-title\">Causa 1 \u2014 Vascular (Oscuridad Azul-Roja)<\/div>\n        <p>La piel de la zona periorbitaria es excepcionalmente fina, de las m\u00e1s finas del rostro. Los vasos sangu\u00edneos superficiales subyacentes se vuelven visibles a trav\u00e9s de la piel, present\u00e1ndose como una decoloraci\u00f3n azul, roja o viol\u00e1cea. Esta apariencia se asocia principalmente con la visibilidad vascular, a menudo influenciada por la ralentizaci\u00f3n de la microcirculaci\u00f3n y la dilataci\u00f3n de los vasos.<\/p>\n        <p>Las ojeras vasculares suelen ser m\u00e1s prominentes despu\u00e9s de dormir mal, deshidrataci\u00f3n o fatiga, y tienen un tono azul-rojo en lugar de un tono marr\u00f3n.<\/p>\n        <p><strong>Los activos aclarantes no son la intervenci\u00f3n principal aqu\u00ed.<\/strong> La cafe\u00edna (vasoconstrictora y ayuda a reducir la hinchaz\u00f3n), el dip\u00e9ptido-2 (favorece el equilibrio de fluidos) y los derivados de la vitamina K (favorecen la recuperaci\u00f3n de la decoloraci\u00f3n relacionada con la sangre) son m\u00e1s relevantes para abordar las preocupaciones vasculares.<\/p>\n      <\/div>\n\n      <div class=\"cause-card\">\n        <div class=\"cause-card-title\">Causa 2 \u2014 Estructural \/ Sombreado<\/div>\n        <p>La p\u00e9rdida de volumen en la zona periorbitaria \u2014atrofia de la almohadilla de grasa, profundizaci\u00f3n del surco lagrimal\u2014 crea un efecto de sombra que se percibe como oscuridad. Este es un problema estructural tridimensional, no un problema de pigmentaci\u00f3n.<\/p>\n        <p><strong>Los activos aclarantes t\u00f3picos no pueden abordar directamente las causas estructurales.<\/strong> Los p\u00e9ptidos que favorecen el col\u00e1geno y la elastina (acetil tetrap\u00e9ptido-5, palmitoil trip\u00e9ptido-1) y los activos formadores de pel\u00edcula que mejoran la apariencia de las irregularidades del contorno pueden reducir la apariencia de las sombras bajo los ojos.<\/p>\n      <\/div>\n\n      <div class=\"cause-card\">\n        <div class=\"cause-card-title\">Causa 3 \u2014 Pigmentaci\u00f3n (Oscuridad Marr\u00f3n)<\/div>\n        <p>La hiperpigmentaci\u00f3n periorbitaria real \u2014decoloraci\u00f3n marr\u00f3n relacionada con la melanina en la epidermis y la dermis\u2014 es el objetivo principal de los activos aclarantes. Es m\u00e1s com\u00fan en:<\/p>\n        <ul>\n          <li>Tipos de piel Fitzpatrick III\u2013VI, donde la melanog\u00e9nesis es m\u00e1s propensa a la pigmentaci\u00f3n<\/li>\n          <li>Casos postinflamatorios (dermatitis de contacto al\u00e9rgica por productos oculares, frotamiento cr\u00f3nico)<\/li>\n          <li>Zona periorbitaria expuesta a los rayos UV en personas con tendencia a la hiperpigmentaci\u00f3n<\/li>\n        <\/ul>\n        <p>Las ojeras de tono marr\u00f3n que persisten independientemente del estado de sue\u00f1o o hidrataci\u00f3n, y que empeoran con la exposici\u00f3n al sol, est\u00e1n predominantemente impulsadas por la pigmentaci\u00f3n.<\/p>\n      <\/div>\n\n      <h2>Por qu\u00e9 la Glabridina es Adecuada para la Pigmentaci\u00f3n Periorbitaria<\/h2>\n\n      <h3>El Mecanismo Antiinflamatorio Aborda la V\u00eda Principal de la PIH<\/h3>\n\n      <p>La PIH periorbitaria \u2014por al\u00e9rgenos, fricci\u00f3n o traumatismos menores repetidos por frotamiento ocular\u2014 sigue v\u00edas de melanog\u00e9nesis inflamatoria que implican la se\u00f1alizaci\u00f3n COX\/PGE\u2082, similar a la PIH en otras partes del rostro. La actividad inhibidora de la COX de la glabridina ayuda a modular este mecanismo, no solo el s\u00edntoma.<\/p>\n\n      <p>Para personas con antecedentes de reacciones periorbitarias al\u00e9rgicas (dermatitis de contacto cosm\u00e9tica, sensibilidad a gotas para los ojos), el origen inflamatorio de sus ojeras est\u00e1 estrechamente asociado con los mecanismos que la glabridina ayuda a modular.<\/p>\n\n      <h3>Perfil de Seguridad \u2014 Cr\u00edtico para la Zona Periorbitaria<\/h3>\n\n      <p>La zona periorbitaria es la zona m\u00e1s sensible del rostro. La piel, m\u00e1s fina y permeable, significa que los activos irritantes o sensibilizantes pueden generar reacciones adversas m\u00e1s pronunciadas en algunas personas. La misma prueba de parche humano cerrada de terceros que respald\u00f3 la seguridad d\u00e9rmica de la glabridina (30 sujetos, cero reacciones adversas observadas, Informe N.\u00ba GZA01-23080632-JC-01) respalda su tolerabilidad en las condiciones probadas. La glabridina a las concentraciones recomendadas generalmente se tolera bien en condiciones de uso estandarizadas.<\/p>\n\n      <p>Por el contrario, activos como el \u00e1cido k\u00f3jico (potencial de sensibilizaci\u00f3n reportado), la L-\u00e1cido asc\u00f3rbico a alta dosis (bajo pH y potencial de irritaci\u00f3n en condiciones de barrera comprometida) o los retinoides (potencial de irritaci\u00f3n en piel periorbitaria sensible) conllevan consideraciones de riesgo elevadas en la zona ocular.<\/p>\n\n      <h3>Eficacia a Baja Concentraci\u00f3n<\/h3>\n\n      <p>El estudio cl\u00ednico en humanos que demuestra una reducci\u00f3n del 16,8% MI a una concentraci\u00f3n activa del 0,03% proporciona una referencia relevante para el control de la pigmentaci\u00f3n t\u00f3pica, incluidas las consideraciones para la formulaci\u00f3n de la zona ocular. Un aclaramiento eficaz puede lograrse a concentraciones que no supongan un estr\u00e9s excesivo en la piel periorbitaria fina y sensible. Un nivel de uso objetivo del 0,1\u20130,2% de activo proporciona un margen pr\u00e1ctico por encima de la concentraci\u00f3n estudiada, sin requerir dosis m\u00e1s altas que puedan aumentar las consideraciones de tolerabilidad.<\/p>\n\n      <h2>Nivel de uso recomendado<\/h2>\n\n      <p><strong>0,1\u20130,2% de activo<\/strong> en la formulaci\u00f3n final.<\/p>\n\n      <p>Este rango proporciona una posible inhibici\u00f3n de la tirosinasa y actividad antiinflamatoria, al tiempo que se mantiene coherente con las observaciones de tolerabilidad de las pruebas de parche. A 0,03%, el aclaramiento cl\u00ednico fue estad\u00edsticamente significativo a partir de la semana 1; el 0,1\u20130,2% de activo puede proporcionar un potencial de eficacia mejorado en un plazo comparable.<\/p>\n\n      <h2>Sistema de Activos Complementarios para la Zona Ocular<\/h2>\n\n      <h3>Para Ojeras con Predominio de Pigmentaci\u00f3n<\/h3>\n\n      <div class=\"table-wrap\">\n        <table>\n          <thead>\n            <tr>\n              <th>Activo<\/th>\n              <th>Mecanismo<\/th>\n              <th>Racional para la Zona Ocular<\/th>\n            <\/tr>\n          <\/thead>\n          <tbody>\n            <tr>\n              <td><strong>Glabridina<\/strong> (principal)<\/td>\n              <td>Inhibici\u00f3n de la tirosinasa + antiinflamatorio COX<\/td>\n              <td>Contribuye tanto a la regulaci\u00f3n de la producci\u00f3n de melanina como a las v\u00edas inflamatorias relacionadas con la PIH<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Niacinamida<\/strong><\/td>\n              <td>Inhibici\u00f3n de la transferencia de melanosomas<\/td>\n              <td>Modulaci\u00f3n aguas abajo; bien tolerado en la zona periorbitaria<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Cafe\u00edna<\/strong><\/td>\n              <td>Vasoconstrictor; ayuda a reducir la hinchaz\u00f3n<\/td>\n              <td>Aborda de forma conjunta el componente vascular que a menudo acompa\u00f1a a las ojeras por pigmentaci\u00f3n<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Dip\u00e9ptido-2<\/strong><\/td>\n              <td>Soporte linf\u00e1tico; efecto antiedema<\/td>\n              <td>Reduce la hinchaz\u00f3n que contribuye a la apariencia de sombra<\/td>\n            <\/tr>\n          <\/tbody>\n        <\/table>\n      <\/div>\n\n      <h3>Para Ojeras de Etiolog\u00eda Mixta (Pigmentaci\u00f3n + Vascular)<\/h3>\n\n      <div class=\"table-wrap\">\n        <table>\n          <thead>\n            <tr>\n              <th>Activo<\/th>\n              <th>Mecanismo<\/th>\n            <\/tr>\n          <\/thead>\n          <tbody>\n            <tr>\n              <td><strong>Glabridina<\/strong> (0,1\u20130,2% de activo)<\/td>\n              <td>Pigmentaci\u00f3n: inhibici\u00f3n de la tirosinasa + antiinflamatorio COX<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Cafe\u00edna<\/strong> (1\u20133%)<\/td>\n              <td>Vascular: vasoconstrictor; reduce la apariencia de acumulaci\u00f3n microcirculatoria<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Dip\u00e9ptido-2<\/strong> (2\u20134 ppm t\u00edpico)<\/td>\n              <td>Vascular\/estructural: soporte linf\u00e1tico; efecto antiedema<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Niacinamida<\/strong> (2\u20133%)<\/td>\n              <td>Pigmentation: melanosome transfer modulation<\/td>\n            <\/tr>\n            <tr>\n              <td><strong>Acetyl tetrapeptide-5<\/strong><\/td>\n              <td>Structural: lymphatic support; anti-edema activity<\/td>\n            <\/tr>\n          <\/tbody>\n        <\/table>\n      <\/div>\n\n      <h2>Formulation Considerations for the Eye Area<\/h2>\n\n      <h3>Texture<\/h3>\n\n      <p>Eye creams and eye serums require specific texture adjustments compared to standard facial formulations:<\/p>\n      <ul>\n        <li><strong>Very light emulsion<\/strong> o <strong>gel-cream<\/strong> for the under-eye area \u2014 avoid heavy occlusive textures that can cause milia in the thin periorbital skin<\/li>\n        <li><strong>Low oil content<\/strong> (\u226415% in O\/W emulsion) \u2014 higher oil fractions increase milia risk<\/li>\n        <li><strong>Non-comedogenic emollients<\/strong> \u2014 dimethicone, cyclopentasiloxane, light esters (caprylic\/capric triglyceride)<\/li>\n      <\/ul>\n\n      <h3>Grade Selection for Eye Formulations<\/h3>\n\n      <div class=\"table-wrap\">\n        <table>\n          <thead>\n            <tr>\n              <th>Formato<\/th>\n              <th>Grado recomendado<\/th>\n              <th>Notas<\/th>\n            <\/tr>\n          <\/thead>\n          <tbody>\n            <tr>\n              <td>Water-based eye serum<\/td>\n              <td>Glabridina hidrosoluble (HP-\u03b2-CD) al 1\u20133%<\/td>\n              <td>Direct aqueous dispersion; co-solvent may not be required depending on system design<\/td>\n            <\/tr>\n            <tr>\n              <td>Light O\/W eye cream<\/td>\n              <td>40% white powder (pre-dissolved in PG or BG at cool-down)<\/td>\n              <td>Polyol concentration may support dissolution depending on formulation conditions<\/td>\n            <\/tr>\n            <tr>\n              <td>Oil-serum eye treatment<\/td>\n              <td>90% oil-soluble glabridin<\/td>\n              <td>0.2% in oil fraction; designed to minimize sedimentation risk under proper formulation conditions<\/td>\n            <\/tr>\n          <\/tbody>\n        <\/table>\n      <\/div>\n\n      <h3>pH Target<\/h3>\n\n      <p>pH 4.5\u20135.5 \u2014 generally compatible with glabridin stability range and physiological periorbital skin pH. Critically, this range also supports barrier function in thin, more permeable periorbital skin, where pH imbalance may affect tolerance more noticeably.<\/p>\n\n      <p>Buffer with citric acid\/sodium citrate or lactic acid\/sodium lactate. Lactic acid is a good choice for eye area products \u2014 it is naturally present in skin NMF, supports hydration, and is generally well-tolerated in low concentrations in periorbital formulations.<\/p>\n\n      <h3>Preservative Considerations<\/h3>\n\n      <p>La piel fina y permeable del \u00e1rea periorbital puede aumentar la sensibilidad local y el potencial de penetraci\u00f3n de los ingredientes en la formulaci\u00f3n. Seleccione conservantes con un historial de uso bien establecido en formulaciones oft\u00e1lmicas o para el \u00e1rea de los ojos. Los parabenos tienen un largo historial de uso seguro en productos para los ojos. El fenoxietanol en concentraciones t\u00edpicas (\u22641%) es ampliamente aceptado. Generalmente se evitan los conservantes de la familia de las isotiazolinonas en las formulaciones para el \u00e1rea de los ojos debido a preocupaciones sobre la sensibilizaci\u00f3n.<\/p>\n\n      <h3>Embalaje<\/h3>\n\n      <p>Bomba sin aire o cuentagotas de vidrio con cierre herm\u00e9tico. Los formatos de tarro abierto generalmente no se prefieren para los productos del \u00e1rea de los ojos: el contacto repetido con los dedos puede aumentar el riesgo de contaminaci\u00f3n, y los requisitos del sistema conservante son particularmente importantes para las formulaciones periorbitales debido a la mayor sensibilidad y el uso frecuente cerca del \u00e1rea de los ojos.<\/p>\n\n      <h2>Formulaci\u00f3n Aclaradora para el \u00c1rea de los Ojos \u2014 Esquema Estructural<\/h2>\n\n      <div class=\"table-wrap\">\n        <table>\n          <thead>\n            <tr>\n              <th>Fase<\/th>\n              <th>Ingrediente<\/th>\n              <th>Objetivo %<\/th>\n              <th>Funci\u00f3n<\/th>\n            <\/tr>\n          <\/thead>\n          <tbody>\n            <tr>\n              <td>Fase acuosa<\/td>\n              <td>Agua purificada<\/td>\n              <td>c.s.<\/td>\n              <td>Portador<\/td>\n            <\/tr>\n            <tr>\n              <td>Fase acuosa<\/td>\n              <td>\u00c1cido l\u00e1ctico \/ Lactato de sodio<\/td>\n              <td>Tamp\u00f3n<\/td>\n              <td>pH 4.8\u20135.2 antes de los activos<\/td>\n            <\/tr>\n            <tr>\n              <td>Fase acuosa<\/td>\n              <td>EDTA dis\u00f3dico<\/td>\n              <td>0.05%<\/td>\n              <td>Quelaci\u00f3n de metales<\/td>\n            <\/tr>\n            <tr>\n              <td>Fase acuosa<\/td>\n              <td>Niacinamida<\/td>\n              <td>2\u20133%<\/td>\n              <td>Modulaci\u00f3n de la transferencia de melanosomas<\/td>\n            <\/tr>\n            <tr>\n              <td>Fase acuosa<\/td>\n              <td>Cafe\u00edna<\/td>\n              <td>1\u20132%<\/td>\n              <td>Componente vascular; reducci\u00f3n de la hinchaz\u00f3n<\/td>\n            <\/tr>\n            <tr>\n              <td>Fase acuosa<\/td>\n              <td>Dip\u00e9ptido-2<\/td>\n              <td>Seg\u00fan recomendaci\u00f3n del proveedor<\/td>\n              <td>Soporte linf\u00e1tico; actividad antiedema<\/td>\n            <\/tr>\n            <tr>\n              <td>Fase acuosa<\/td>\n              <td>Acetyl tetrapeptide-5<\/td>\n              <td>Seg\u00fan recomendaci\u00f3n del proveedor<\/td>\n              <td>Soporte linf\u00e1tico; actividad antiedema<\/td>\n            <\/tr>\n            <tr>\n              <td>Fase acuosa<\/td>\n              <td>\u00c1cido hialur\u00f3nico (bajo peso molecular)<\/td>\n              <td>1\u20130.5%<\/td>\n              <td>Hidrataci\u00f3n periorbital<\/td>\n            <\/tr>\n            <tr>\n              <td>Fase oleosa<\/td>\n              <td>Triglic\u00e9rido capr\u00edlico\/c\u00e1prico<\/td>\n              <td>5\u201310%<\/td>\n              <td>Emoliente ligero, no comedog\u00e9nico<\/td>\n            <\/tr>\n            <tr>\n              <td>Fase oleosa<\/td>\n              <td>Dimeticona<\/td>\n              <td>1\u20133%<\/td>\n              <td>Sensorial; no comedog\u00e9nico<\/td>\n            <\/tr>\n            <tr>\n              <td>Emulsionante<\/td>\n              <td>Sistema emulsionante sin PEG<\/td>\n              <td>Seg\u00fan sea necesario<\/td>\n              <td>Emulsi\u00f3n O\/W ligera<\/td>\n            <\/tr>\n            <tr>\n              <td>Enfriamiento<\/td>\n              <td><strong>Glabridina<\/strong> (10% soluble en agua o 40% predissuelto)<\/td>\n              <td>0,1\u20130,2% de activo<\/td>\n              <td>Ancla principal de aclarado<\/td>\n            <\/tr>\n            <tr>\n              <td>Enfriamiento<\/td>\n              <td>Tocoferoles mixtos<\/td>\n              <td>0,2%<\/td>\n              <td>Antioxidante<\/td>\n            <\/tr>\n            <tr>\n              <td>Enfriamiento<\/td>\n              <td>Preservativo<\/td>\n              <td>Seg\u00fan sea necesario<\/td>\n              <td>Sistema apropiado para el \u00e1rea periorbital<\/td>\n            <\/tr>\n            <tr>\n              <td>Final<\/td>\n              <td>Verificaci\u00f3n de pH<\/td>\n              <td>Objetivo 4.5\u20135.5<\/td>\n              <td>Despu\u00e9s de todas las adiciones<\/td>\n            <\/tr>\n          <\/tbody>\n        <\/table>\n      <\/div>\n\n      <div class=\"callout\">\n        <p>Cada lote se env\u00eda con COA, TDS y SDS\/MSDS. Pruebas adicionales disponibles bajo petici\u00f3n.<\/p>\n      <\/div>\n\n      <!-- Related -->\n      <div class=\"related-section\">\n        <h2>Recursos relacionados<\/h2>\n        <div class=\"related-links\">\n          <a class=\"related-link\" href=\"https:\/\/glabridinchina.com\/es\/glabridin\/\">\n            <span>Gu\u00eda de Glabridina para Formulaci\u00f3n Cosm\u00e9tica \u2014 Referencia T\u00e9cnica Completa<br>\n            <small style=\"color:var(--color-text-muted);font-weight:400\">Matriz completa de mecanismos y grados, y gu\u00eda de aplicaci\u00f3n<\/small><\/span>\n            <span class=\"related-link-arrow\">\u2192<\/span>\n          <\/a>\n          <a class=\"related-link\" href=\"https:\/\/glabridinchina.com\/es\/can-glabridin-be-used-in-sensitive-skin-products\/\">\n            <span>\u00bfSe puede usar la glabridina en productos para pieles sensibles?<br>\n            <small style=\"color:var(--color-text-muted);font-weight:400\">Perfil de seguridad y mecanismo antiinflamatorio<\/small><\/span>\n            <span class=\"related-link-arrow\">\u2192<\/span>\n          <\/a>\n          <a class=\"related-link\" href=\"https:\/\/glabridinchina.com\/es\/glabridin-niacinamide-complementary-mechanisms-in-multilevel-brightening\/\">\n            <span>Glabridina y Niacinamida: Mecanismos Complementarios en el Aclaramiento Multinivel<br>\n            <small style=\"color:var(--color-text-muted);font-weight:400\">Cobertura de brillo aguas arriba y aguas abajo<\/small><\/span>\n            <span class=\"related-link-arrow\">\u2192<\/span>\n          <\/a>\n          <a class=\"related-link\" href=\"https:\/\/glabridinchina.com\/es\/what-ph-range-does-glabridin-require-in-cosmetic-formulations\uff1f\/\">\n            <span>\u00bfQu\u00e9 rango de pH requiere la Glabridina en formulaciones cosm\u00e9ticas?<br>\n            <small style=\"color:var(--color-text-muted);font-weight:400\">Gesti\u00f3n del pH para formatos de piel sensible<\/small><\/span>\n            <span class=\"related-link-arrow\">\u2192<\/span>\n          <\/a>\n        <\/div>\n      <\/div>\n\n      <!-- CTA -->\n      <div class=\"cta-box\">\n        <div class=\"cta-box-text\">\n          <strong>Solicitar muestras, COA o consulta t\u00e9cnica<\/strong>\n          glabridinchina.com \u00b7 jelly@huataibio.com \u00b7 +86 17868678161\n        <\/div>\n        <a class=\"cta-btn\" href=\"https:\/\/glabridinchina.com\/es\/Parsley-Extract\/\">Cont\u00e1ctenos \u2192<\/a>\n      <\/div>\n\n      <!-- References -->\n      <div class=\"references\">\n        <h2>Referencias<\/h2>\n        <ol>\n          <li>Yokota T, Nishio H, Kubota Y, Mizoguchi M. El efecto inhibidor de la glabridina de extractos de regaliz en la melanog\u00e9nesis y la inflamaci\u00f3n. <em>Pigment Cell Research<\/em>, 11(6), 355\u2013361, 1998. DOI: 10.1111\/j.1600-0749.1998.tb00494.x.<\/li>\n          <li>, 12(1), 212\u2013222, 2023. DOI: 10.1016\/j.fshw.2022.07.011. <em>Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.<\/em>British Journal of Dermatology<\/li>\n          <li>Guangdong Weipu Testing Technology Co., Ltd. (CMA N.\u00ba 202119135666). Informe N.\u00ba GZA01-23080632-JC-01. Estudio de eficacia de blanqueamiento de la piel humana + prueba de parche, 0.03% Glabridina. Encargado por Huatai Bio-Fine Chemical.<\/li>\n        <\/ol>\n      <\/div>\n\n      <div class=\"article-footer\">\n        <p>Para formuladores cosm\u00e9ticos profesionales y audiencias de I+D. No constituye asesoramiento regulatorio.<br>\n        Publicado en 2026 \u2014 Huatai Bio-Fine Chemical, Xi'an, Shaanxi, China.<\/p>\n      <\/div>\n\n    <\/article>\n  <\/div>\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>Aplicaci\u00f3n Glabridina \u00c1rea de los Ojos Ojeras Las ojeras se encuentran entre las preocupaciones est\u00e9ticas m\u00e1s comunes en el cuidado de la piel, y entre las que se formulan incorrectamente con mayor frecuencia. Las\u2026<\/p>","protected":false},"author":8,"featured_media":5795,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[411],"tags":[],"class_list":["post-14275","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-application-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.8 (Yoast SEO v24.2) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Eye Area Brightening: Addressing Dark Circles with Glabridin | Huatai Bio-Fine Chemical<\/title>\n<meta name=\"description\" content=\"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/glabridinchina.com\/es\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Eye Area Brightening: Addressing Dark Circles with Glabridin\" \/>\n<meta property=\"og:description\" content=\"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/glabridinchina.com\/es\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\" \/>\n<meta property=\"og:site_name\" content=\"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-25T09:21:10+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-25T09:25:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1242\" \/>\n\t<meta property=\"og:image:height\" content=\"699\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Huatai\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Huatai\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\"},\"author\":{\"name\":\"Huatai\",\"@id\":\"https:\/\/glabridinchina.com\/#\/schema\/person\/1fc9183390cde309170faf98dbabcaab\"},\"headline\":\"Eye Area Brightening: Addressing Dark Circles with Glabridin\",\"datePublished\":\"2026-06-25T09:21:10+00:00\",\"dateModified\":\"2026-06-25T09:25:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\"},\"wordCount\":1514,\"publisher\":{\"@id\":\"https:\/\/glabridinchina.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg\",\"articleSection\":[\"Application Guides\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\",\"url\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\",\"name\":\"Eye Area Brightening: Addressing Dark Circles with Glabridin | Huatai Bio-Fine Chemical\",\"isPartOf\":{\"@id\":\"https:\/\/glabridinchina.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg\",\"datePublished\":\"2026-06-25T09:21:10+00:00\",\"dateModified\":\"2026-06-25T09:25:43+00:00\",\"description\":\"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.\",\"breadcrumb\":{\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage\",\"url\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg\",\"contentUrl\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg\",\"width\":1242,\"height\":699,\"caption\":\"Glabridin ingredient\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/glabridinchina.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Eye Area Brightening: Addressing Dark Circles with Glabridin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/glabridinchina.com\/#website\",\"url\":\"https:\/\/glabridinchina.com\/\",\"name\":\"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.\",\"description\":\"Huatai Bio-Fine Chemicals: ISO-certified manufacturer of high-purity skincare ingredients like Glabridin and Tranexamic Acid. Offering flexible supply with full documentation for brands &amp; OEMs worldwide.\",\"publisher\":{\"@id\":\"https:\/\/glabridinchina.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/glabridinchina.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/glabridinchina.com\/#organization\",\"name\":\"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.\",\"url\":\"https:\/\/glabridinchina.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/glabridinchina.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2024\/10\/\u516c\u53f8LOGO.webp\",\"contentUrl\":\"https:\/\/glabridinchina.com\/wp-content\/uploads\/2024\/10\/\u516c\u53f8LOGO.webp\",\"width\":1278,\"height\":783,\"caption\":\"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.\"},\"image\":{\"@id\":\"https:\/\/glabridinchina.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/glabridinchina.com\/#\/schema\/person\/1fc9183390cde309170faf98dbabcaab\",\"name\":\"Huatai\",\"url\":\"https:\/\/glabridinchina.com\/es\/author\/huatai\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Eye Area Brightening: Addressing Dark Circles with Glabridin | Huatai Bio-Fine Chemical","description":"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/glabridinchina.com\/es\/eye-area-brightening-addressing-dark-circles-with-glabridin\/","og_locale":"es_ES","og_type":"article","og_title":"Eye Area Brightening: Addressing Dark Circles with Glabridin","og_description":"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.","og_url":"https:\/\/glabridinchina.com\/es\/eye-area-brightening-addressing-dark-circles-with-glabridin\/","og_site_name":"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.","article_published_time":"2026-06-25T09:21:10+00:00","article_modified_time":"2026-06-25T09:25:43+00:00","og_image":[{"width":1242,"height":699,"url":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg","type":"image\/jpeg"}],"author":"Huatai","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Huatai"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#article","isPartOf":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/"},"author":{"name":"Huatai","@id":"https:\/\/glabridinchina.com\/#\/schema\/person\/1fc9183390cde309170faf98dbabcaab"},"headline":"Eye Area Brightening: Addressing Dark Circles with Glabridin","datePublished":"2026-06-25T09:21:10+00:00","dateModified":"2026-06-25T09:25:43+00:00","mainEntityOfPage":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/"},"wordCount":1514,"publisher":{"@id":"https:\/\/glabridinchina.com\/#organization"},"image":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage"},"thumbnailUrl":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg","articleSection":["Application Guides"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/","url":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/","name":"Eye Area Brightening: Addressing Dark Circles with Glabridin | Huatai Bio-Fine Chemical","isPartOf":{"@id":"https:\/\/glabridinchina.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage"},"image":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage"},"thumbnailUrl":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg","datePublished":"2026-06-25T09:21:10+00:00","dateModified":"2026-06-25T09:25:43+00:00","description":"A technical guide to formulating dark circle treatments using glabridin \u2014 covering the three distinct causes of periorbital darkness, active system design, grade selection, and formulation considerations for the periorbital zone. From Huatai, manufacturer of high-purity glabridin since 2008.","breadcrumb":{"@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#primaryimage","url":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg","contentUrl":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2025\/10\/Glabridin-ingredient.jpg","width":1242,"height":699,"caption":"Glabridin ingredient"},{"@type":"BreadcrumbList","@id":"https:\/\/glabridinchina.com\/eye-area-brightening-addressing-dark-circles-with-glabridin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/glabridinchina.com\/"},{"@type":"ListItem","position":2,"name":"Eye Area Brightening: Addressing Dark Circles with Glabridin"}]},{"@type":"WebSite","@id":"https:\/\/glabridinchina.com\/#website","url":"https:\/\/glabridinchina.com\/","name":"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.","description":"Huatai Bio-Fine Chemicals: ISO-certified manufacturer of high-purity skincare ingredients like Glabridin and Tranexamic Acid. Offering flexible supply with full documentation for brands &amp; OEMs worldwide.","publisher":{"@id":"https:\/\/glabridinchina.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/glabridinchina.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/glabridinchina.com\/#organization","name":"Shaanxi Huatai Bio-Fine Chemical Co., Ltd.","url":"https:\/\/glabridinchina.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/glabridinchina.com\/#\/schema\/logo\/image\/","url":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2024\/10\/\u516c\u53f8LOGO.webp","contentUrl":"https:\/\/glabridinchina.com\/wp-content\/uploads\/2024\/10\/\u516c\u53f8LOGO.webp","width":1278,"height":783,"caption":"Shaanxi Huatai Bio-Fine Chemical Co., Ltd."},"image":{"@id":"https:\/\/glabridinchina.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/glabridinchina.com\/#\/schema\/person\/1fc9183390cde309170faf98dbabcaab","name":"Huatai","url":"https:\/\/glabridinchina.com\/es\/author\/huatai\/"}]}},"_links":{"self":[{"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/posts\/14275","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/comments?post=14275"}],"version-history":[{"count":4,"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/posts\/14275\/revisions"}],"predecessor-version":[{"id":14279,"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/posts\/14275\/revisions\/14279"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/media\/5795"}],"wp:attachment":[{"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/media?parent=14275"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/categories?post=14275"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/glabridinchina.com\/es\/wp-json\/wp\/v2\/tags?post=14275"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}